دورية أكاديمية
أعرض في EDS

Surgical outcomes of excisional goniotomy using the kahook dual blade in severe and refractory glaucoma: 12-month results.

التفاصيل البيبلوغرافية
العنوان: Surgical outcomes of excisional goniotomy using the kahook dual blade in severe and refractory glaucoma: 12-month results.
المؤلفون: Bravetti GE; Glaucoma Research Center, Montchoisi Clinic, Swiss Visio, Lausanne, Switzerland. giorgioenrico.bravetti@gmail.com., Gillmann K; Glaucoma Research Center, Montchoisi Clinic, Swiss Visio, Lausanne, Switzerland., Salinas L; Glaucoma Research Center, Montchoisi Clinic, Swiss Visio, Lausanne, Switzerland.; Department of Ophthalmology, North University Hospital Center, Marseille, France., Berdahl JP; Vance Thompson Vision, Sioux Falls, South Dakota, SD, USA., Lazcano-Gomez GS; Asociacion para Evitar la Ceguera, Mexico City, Mexico., Williamson BK; Williamson Eye, Center Baton Rouge, Baton Rouge, LA, USA., Dorairaj SK; Mayo Clinic, Jacksonville, FL, USA., Seibold LK; University of Colorado School of Medicine, Aurora, Colorado, CO, USA., Smith S; Medical Eye Associates, South Miami, FL, USA., Aref AA; University of Illinois, Chicago, IL, USA., Darlington JK; Eye Institute, Melbourne, FL, USA., Jimenez-Roman J; Hospital Dr. Luis Sanchez Bulnes, Mexico City, Mexico., Mahootchi A; The Eye Clinic of Florida, Zephyrhills, FL, USA., Mansouri K; Glaucoma Research Center, Montchoisi Clinic, Swiss Visio, Lausanne, Switzerland.; Department of Ophthalmology, University of Colorado School of Medicine, Denver, CO, USA.
المصدر: Eye (London, England) [Eye (Lond)] 2023 Jun; Vol. 37 (8), pp. 1608-1613. Date of Electronic Publication: 2022 Aug 09.
نوع المنشور: Multicenter Study; Journal Article
اللغة: English
بيانات الدورية: Publisher: Nature Publishing Group Country of Publication: England NLM ID: 8703986 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1476-5454 (Electronic) Linking ISSN: 0950222X NLM ISO Abbreviation: Eye (Lond) Subsets: MEDLINE
أسماء مطبوعة: Publication: <2003->: London : Nature Publishing Group
Original Publication: [London : Ophthalmological Society of the United Kingdom, 1987-
مواضيع طبية MeSH: Trabeculectomy*/methods , Glaucoma, Open-Angle*/surgery , Glaucoma*/surgery , Glaucoma*/etiology , Ocular Hypotension*/etiology, Humans ; Intraocular Pressure ; Antiglaucoma Agents ; Tonometry, Ocular ; Treatment Outcome ; Retrospective Studies
مستخلص: Objectives: To describe the efficacy and safety of goniotomy with trabecular meshwork excision using the Kahook Dual Blade (KDB, New World Medical Inc., Rancho Cucamonga, CA) in patients with severe or refractory glaucoma.
Methods: This retrospective multicentre case series reports on 40 eyes with severe or refractory open-angle glaucoma that underwent standalone or combined KDB goniotomy and were followed for 12 months post-operatively in the United-States, Mexico and Switzerland. Surgical success was defined as an intraocular pressure (IOP) reduction ≥20% from baseline at 12 months, with fewer medications than preoperatively. Mean IOP and antiglaucoma medication reduction, probabilities of achieving an IOP ≤16 or 18 mmHg, and adverse events were also analysed.
Results: Mean IOP decreased from 18.1 ± 5.0 mmHg at baseline to 14.8 ± 3.7 mmHg at 12 months (18.2% reduction, P < 0.001). Concomitantly, the mean number of glaucoma medications decreased from 2.5 ± 1.4 to 1.7 ± 1.2 (32% reduction, P = 0.002). The proportion of eyes achieving an IOP reduction of more than 20% from baseline was 37.5% (n = 15) at 12 months. At 12 months, 67.5% and 82.5% achieved a medicated IOP ≤ 16 and ≤18 mmHg, respectively. No severe complications were reported.
Conclusion: Excisional goniotomy with KDB achieves a statistically significant IOP and antiglaucoma medication reduction in severe or refractory glaucoma over a period of 12 months. While its efficacy decreases with time, its favourable safety profile makes it a potentially useful primary or adjunctive procedure in high-risk eyes.
(© 2022. The Author(s), under exclusive licence to The Royal College of Ophthalmologists.)
References: Graefes Arch Clin Exp Ophthalmol. 2020 Aug;258(8):1787-1794. (PMID: 32377823)
J Glaucoma. 2019 Aug;28(8):676-684. (PMID: 31162174)
J Glaucoma. 2018 Oct;27(10):869-873. (PMID: 30095603)
Clin Ophthalmol. 2020 Jul 03;14:1891-1897. (PMID: 32694910)
Middle East Afr J Ophthalmol. 2015 Jan-Mar;22(1):25-9. (PMID: 25624670)
Clin Ophthalmol. 2015 Apr 15;9:677-84. (PMID: 25931808)
Acta Ophthalmol. 2021 Jun;99(4):e531-e539. (PMID: 32930515)
J Glaucoma. 2018 Feb;27(2):140-147. (PMID: 29271806)
J Glaucoma. 2018 Oct;27(10):849-855. (PMID: 29979337)
Graefes Arch Clin Exp Ophthalmol. 2013 Nov;251(11):2609-15. (PMID: 24068439)
Am J Ophthalmol. 2013 Mar;155(3):524-529.e2. (PMID: 23218696)
Exp Eye Res. 2009 Apr;88(4):648-55. (PMID: 19239914)
Ophthalmology. 2015 Apr;122(4):748-54. (PMID: 25542521)
Ophthalmology. 2017 Nov;124(11):1579-1588. (PMID: 28601250)
J Glaucoma. 2019 Nov;28(11):1015-1018. (PMID: 31460883)
Asia Pac J Ophthalmol (Phila). 2020 May-Jun;9(3):203-214. (PMID: 32501895)
J Cataract Refract Surg. 2020 Oct;46(10):1408-1415. (PMID: 32483073)
Ophthalmology. 2015 Aug;122(8):1615-24. (PMID: 26092196)
J Glaucoma. 2019 Aug;28(8):744-748. (PMID: 31188228)
J Glaucoma. 2020 Mar;29(3):155-160. (PMID: 32108690)
JAMA. 2014 May 14;311(18):1901-11. (PMID: 24825645)
Am J Ophthalmol. 2012 May;153(5):804-814.e1. (PMID: 22244522)
Expert Rev Med Devices. 2018 Jan;15(1):47-59. (PMID: 29258404)
J Cataract Refract Surg. 2017 Sep;43(9):1197-1201. (PMID: 28991617)
PLoS One. 2017 Aug 29;12(8):e0183142. (PMID: 28850575)
J Glaucoma. 2020 Aug;29(8):639-647. (PMID: 32433094)
Ophthalmol Glaucoma. 2020 Jan - Feb;3(1):40-50. (PMID: 32672640)
Br J Ophthalmol. 2002 Apr;86(4):418-23. (PMID: 11914211)
Adv Ther. 2019 Sep;36(9):2515-2527. (PMID: 31317390)
Am J Ophthalmol. 1951 Nov;34(11):1603-5. (PMID: 14885362)
J Glaucoma. 2014 Jan;23(1):e18-22. (PMID: 24370808)
Ophthalmol Glaucoma. 2019 Sep - Oct;2(5):309-318. (PMID: 32672673)
المشرفين على المادة: 0 (Antiglaucoma Agents)
تواريخ الأحداث: Date Created: 20220809 Date Completed: 20230529 Latest Revision: 20240603
رمز التحديث: 20240603
مُعرف محوري في PubMed: PMC10220026
DOI: 10.1038/s41433-022-02196-y
PMID: 35945340
قاعدة البيانات: MEDLINE
الوصف
تدمد:1476-5454
DOI:10.1038/s41433-022-02196-y